OGN
Organon & Co
Price:  
9.22 
USD
Volume:  
5,303,673.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OGN WACC - Weighted Average Cost of Capital

The WACC of Organon & Co (OGN) is 5.7%.

The Cost of Equity of Organon & Co (OGN) is 10.00%.
The Cost of Debt of Organon & Co (OGN) is 5.50%.

Range Selected
Cost of equity 8.30% - 11.70% 10.00%
Tax rate 15.50% - 18.10% 16.80%
Cost of debt 4.00% - 7.00% 5.50%
WACC 4.4% - 7.0% 5.7%
WACC

OGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.97 1.22
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 11.70%
Tax rate 15.50% 18.10%
Debt/Equity ratio 3.7 3.7
Cost of debt 4.00% 7.00%
After-tax WACC 4.4% 7.0%
Selected WACC 5.7%

OGN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for OGN:

cost_of_equity (10.00%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.97) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.